IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA / Pagliaro, L; Sammarelli, G; Russo, F; Plenteda, C; Todaro, G; Pelagatti, L; Notarfranchi, L; Falcioni, F; Aversa, F; Re, F. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 103:(2018), pp. S79-S79.
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA
Pagliaro, LWriting – Original Draft Preparation
;Sammarelli, G;Plenteda, C;Notarfranchi, L;Falcioni, F;Aversa, F
;
2018-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
